Aug 2026
Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India.
Noncompliance with ET is a clinically significant predictor of inferior outcomes in young women with HR+ EBC, and structured survivorship-focused interventions are essential to improve long-term compliance and survival outcomes.
M. Trikha, Sushmita Rath, Pradeep Ventrapati et al.
· Clinical Breast Cancer · 0 citations